BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Prognosis
25 results:

  • 1. TCEB3 initiates ovarian cancer apoptosis by mediating ubiquitination and degradation of mcl-1.
    Cai Y; Li Y; Xu Y; Yang W; Huang M
    FASEB J; 2024 Apr; 38(8):e23625. PubMed ID: 38661028
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pancreatic Metastasectomy for Secondary Malignancy of the Pancreas: A Single-institution Experience.
    Lee O; Yoon SK; Yoon SJ; Kim H; Han IW; Heo JS; Shin SH
    Anticancer Res; 2024 Feb; 44(2):703-710. PubMed ID: 38307567
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PD-L1 and mcl-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma.
    Zantut-Wittmann DE; Barreto IS; Laus AC; Moreno DA; Moma CA; Maia FFR; Assumpção LVMD; Reis RM
    Mol Cell Endocrinol; 2023 Jun; 570():111931. PubMed ID: 37072108
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
    Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
    J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of immunity- and ferroptosis-related genes for predicting the prognosis of serous ovarian cancer.
    Yuan X; Zhou Q; Zhang F; Zheng W; Liu H; Chen A; Tao Y
    Gene; 2022 Sep; 838():146701. PubMed ID: 35777713
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
    Zhong Y; Le F; Cheng J; Luo C; Zhang X; Wu X; Xu F; Zuo Q; Tan B
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760192
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification and validation of a prognostic index based on a metabolic-genomic landscape analysis of ovarian cancer.
    Zhang QF; Li YK; Chen CY; Zhang XD; Cao L; Quan FF; Zeng X; Wang J; Liu J
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32880385
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer.
    Han Y; Wang Z; Sun S; Zhang Z; Liu J; Jin X; Wu P; Ji T; Ding W; Wang B; Gao Q
    Epigenetics; 2020; 15(1-2):122-133. PubMed ID: 31423895
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic cancer in vitro and in vivo.
    Zhou Y; Liu H; Xue R; Tang W; Zhang S
    Dig Dis Sci; 2018 Dec; 63(12):3367-3375. PubMed ID: 30155839
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR-125b with mcl-1 by regulating mitochondrial apoptosis pathways in ovarian cancer.
    Chen P; Fang X; Xia B; Zhao Y; Li Q; Wu X
    Cancer Med; 2018 Sep; 7(9):4530-4541. PubMed ID: 30030896
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.
    Meiser B; Quinn VF; Mitchell G; Tucker K; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Susman R; Bowen MT; Mills L; Kirk J;
    Eur J Hum Genet; 2018 Jul; 26(7):972-983. PubMed ID: 29599518
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells.
    Lu C; Yang D; Sabbatini ME; Colby AH; Grinstaff MW; Oberlies NH; Pearce C; Liu K
    BMC Cancer; 2018 Feb; 18(1):149. PubMed ID: 29409480
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. O-GlcNAcylation of fumarase maintains tumour growth under glucose deficiency.
    Wang T; Yu Q; Li J; Hu B; Zhao Q; Ma C; Huang W; Zhuo L; Fang H; Liao L; Eugene Chin Y; Jiang Y
    Nat Cell Biol; 2017 Jul; 19(7):833-843. PubMed ID: 28628081
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. BAG3-mediated mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer.
    Habata S; Iwasaki M; Sugio A; Suzuki M; Tamate M; Satohisa S; Tanaka R; Saito T
    Int J Oncol; 2016 Jul; 49(1):402-10. PubMed ID: 27120977
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Combination of chloroquine and GX15-070 (obatoclax) results in synergistic cytotoxicity against pancreatic cancer cells.
    Wang G; Chen S; Edwards H; Cui X; Cui L; Ge Y
    Oncol Rep; 2014 Dec; 32(6):2789-94. PubMed ID: 25333301
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mantle cell lymphoma and diffuse large B-cell lymphoma of the testis: a unique case of composite non-Hodgkin lymphoma.
    Andhavarapu S; Crozier JA; Jiang L; Sher T
    Eur J Haematol; 2014 Dec; 93(6):537-42. PubMed ID: 24750331
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells.
    Qiao Z; Ren S; Li W; Wang X; He M; Guo Y; Sun L; He Y; Ge Y; Yu Q
    Biochem Biophys Res Commun; 2013 Apr; 434(1):95-101. PubMed ID: 23541946
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting mcl-1 gene in pancreatic carcinoma cell.
    Wei SH; Dong K; Lin F; Wang X; Li B; Shen JJ; Zhang Q; Wang R; Zhang HZ
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1055-64. PubMed ID: 18297287
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes.
    Shi X; Liu S; Kleeff J; Friess H; Büchler MW
    Oncology; 2002; 62(4):354-62. PubMed ID: 12138244
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Increased mcl-1 expression is associated with poor prognosis in ovarian carcinomas.
    Shigemasa K; Katoh O; Shiroyama Y; Mihara S; Mukai K; Nagai N; Ohama K
    Jpn J Cancer Res; 2002 May; 93(5):542-50. PubMed ID: 12036450
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.